e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Biomarkers and exacerbations of asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
A. Afonso, K. Verhamme, G. Brusselle, M. Sturkenboom (Rotterdam, Netherlands; Ghent, Belgium)
Source:
Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Session:
Biomarkers and exacerbations of asthma and COPD
Session type:
Poster Discussion
Number:
3359
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Afonso, K. Verhamme, G. Brusselle, M. Sturkenboom (Rotterdam, Netherlands; Ghent, Belgium). β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD. Eur Respir J 2011; 38: Suppl. 55, 3359
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Predictors of exacerbations requiring hospitalisation in patients with stable COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 177s
Year: 2006
Predictors of mortality in COPD patients after hospitalization due to an exacerbation
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Rehospitalizations for an acute exacerbation among patients with COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Predicting mortality in patients hospitalised with acute exacerbations of COPD (AECOPD) requiring assisted ventilation
Source: Annual Congress 2012 - New scientific findings on noninvasive ventilation in the acute setting
Year: 2012
COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Statins and outcome of COPD patients after hospitalization for COPD exacerbations
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010
In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
COPD mortality after severe exacerbations
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020
Polypharmacy in patients hospitalised for acute exacerbation of COPD
Source: Eur Respir J 2014; 44: 791-794
Year: 2014
COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016
Trends in the lifetime risk of COPD exacerbation requiring hospitalisation
Source: Eur Respir J 2013; 42: 964-971
Year: 2013
Risk factors for hospitalization of an acute exacerbation of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 177s
Year: 2006
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
High-risk patients following hospitalisation for an acute exacerbation of COPD
Source: Eur Respir J 2013; 42: 946-955
Year: 2013
The risk of hyperkalemia in COPD and asthma patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
The main reasons of exacerbation and hospitalization of COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 558s
Year: 2007
Polypharmacy in patients with acute exacerbation of COPD
Source: Annual Congress 2011 - COPD management
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept